Drug Shortage Report for ANGELIQ
Report ID | 167449 |
Drug Identification Number | 02268825 |
Brand name | ANGELIQ |
Common or Proper name | Drospirenone /Estradiol-17ß |
Company Name | BAYER INC |
Market Status | MARKETED |
Active Ingredient(s) | ESTRADIOL DROSPIRENONE |
Strength(s) | 1.0MG 1.0MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 28's |
ATC code | G03FA |
ATC description | PROGESTOGENS AND ESTROGENS IN COMBINATION |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2022-08-22 |
Actual start date | 2022-08-24 |
Estimated end date | 2022-08-30 |
Actual end date | 2022-08-26 |
Shortage status | Resolved |
Updated date | 2022-08-29 |
Company comments | Supply constraints |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2022-08-29 | French | Compare |
v6 | 2022-08-29 | English | Compare |
v5 | 2022-08-25 | French | Compare |
v4 | 2022-08-25 | English | Compare |
v3 | 2022-08-23 | English | Compare |
v2 | 2022-08-19 | French | Compare |
v1 | 2022-08-19 | English | Compare |
Showing 1 to 7 of 7